MSI-H or dMMR Advanced Solid Tumors
3 clinical trials · Condition
◉ Watch MSI-H or dMMR Advanced Solid Tumors
| Record | Firm | Date |
|---|---|---|
| A Study of Anlotinib Combined With AK105 Injection in Subjects With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Advanced Solid Tumor (NCT04291248) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-03-01 |
Track MSI-H or dMMR Advanced Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.